UiPath, Inc. (PATH) › Analysis

UiPath, Inc. (PATH) stock analysis, February 17, 2026: PATH at $11.05 tests multi-month lows after WorkFusion rally fully reversed

Published February 17, 2026 · PATH chart, levels and live analysis

Executive Summary

UiPath shares declined 5.43% to $11.05 since the February 12 report, extending the post-acquisition correction to a cumulative 17.03% decline from the February 10 peak of $13.29. The stock now trades at its lowest level in the analyzed period, down 32.55% year-to-date, with the WorkFusion acquisition failing to provide sustained support amid intensifying competitive pressures from Palantir's AI platform dominance and broader market concerns ahead of Q4 FY2026 earnings on March 11.

Key Updates

UiPath shares fell 5.43% to $11.05 over the past five days, marking a continuation of the steep correction that began after the brief post-acquisition rally. The stock has now declined 14.96% over the past five trading sessions and 22.91% over the past month, establishing a new multi-month low. The 32.55% year-to-date decline significantly underperforms the broader market and reflects growing investor skepticism despite the strategic WorkFusion acquisition announced February 6. The upcoming Q4 FY2026 earnings release scheduled for March 11 represents a critical inflection point, as management must demonstrate tangible revenue acceleration and margin expansion to justify the current valuation amid intensifying competition.

Current Trend

UiPath has established a clear downtrend with the stock breaking below all previous support levels. The 32.55% year-to-date decline positions PATH among the worst-performing enterprise software stocks in 2026. The current price of $11.05 represents a 17.03% decline from the February 10 post-acquisition peak of $13.29, indicating that the market has completely reversed its initial positive reaction to the WorkFusion deal. The 6-month performance of +0.87% demonstrates the stock's inability to generate sustained momentum, with recent weakness accelerating dramatically. Technical deterioration is evident across all timeframes, with the 1-month decline of 22.91% suggesting capitulation selling. The stock has failed to establish any meaningful support levels, with each bounce being sold aggressively.

Investment Thesis

The investment thesis centers on UiPath's transition from traditional robotic process automation (RPA) to agentic automation powered by AI agents, positioning the company to capture a larger share of the projected $20.79 billion RPA market by 2032. The WorkFusion acquisition strengthens UiPath's vertical capabilities in financial services, particularly in compliance-heavy workflows including AML, KYC, sanctions screening, and transaction monitoring. However, the thesis faces mounting challenges from competitive dynamics, with Palantir emerging as a formidable competitor through its AI Operating System approach that delivers compressed sales cycles and superior customer engagement. The market's 28.47% projected CAGR through 2032 validates the opportunity, but platform consolidation favors vendors commanding 30-40% higher enterprise deal values, creating execution risk for UiPath's market position.

Thesis Status

The investment thesis is deteriorating as competitive pressures intensify and the market questions UiPath's ability to defend its leadership position. While the WorkFusion acquisition provides strategic assets in financial services compliance, the stock's 32.55% year-to-date decline suggests investors are skeptical about integration execution and near-term revenue contribution. Palantir's "incredible" Q4 earnings with 60% projected growth in 2026 and its "n of 1" positioning in AI-driven decision-making directly threatens UiPath's enterprise automation franchise. The upcoming March 11 earnings call represents a critical test, as management must demonstrate that the transition to agentic automation is translating into accelerating revenue growth and expanding margins. The thesis requires validation through concrete evidence of customer adoption, deal velocity improvement, and competitive differentiation against platforms like Palantir that are achieving significantly faster growth rates.

Key Drivers

The primary near-term catalyst is UiPath's Q4 FY2026 earnings release scheduled for March 11, 2026, which will provide critical visibility into revenue growth, margin trajectory, and management's ability to articulate a compelling agentic automation strategy. The WorkFusion acquisition closed in Q1 FY2027, meaning its financial impact will not appear in the upcoming results but management commentary on integration plans and pipeline development will be scrutinized. Competitive dynamics have intensified significantly, with Palantir's exceptional Q4 performance demonstrating 60% projected growth and its bootcamp model compressing sales cycles from months to weeks, setting a high bar for automation platform vendors. The broader RPA market growth to $20.79 billion by 2032 at a 28.47% CAGR provides structural tailwinds, but platform consolidation favors vendors demonstrating superior AI integration and faster time-to-value. Adjacent competitive developments including new automation platforms from laboratory sciences vendors signal that AI-driven automation is becoming increasingly democratized, potentially commoditizing traditional RPA capabilities.

Technical Analysis

UiPath exhibits severe technical deterioration across all timeframes, with the stock trading at $11.05 representing a new multi-month low and a 32.55% year-to-date decline. The recent price action shows accelerating downward momentum, with the 1-day decline of 2.34%, 5-day decline of 14.96%, and 1-month decline of 22.91% indicating capitulation selling. The stock has completely reversed the 11.13% post-acquisition rally that peaked at $13.29 on February 10, demonstrating the market's skepticism about the WorkFusion transaction's strategic value. No meaningful support levels have held, with each attempted bounce being sold aggressively. The 6-month performance of +0.87% masks the recent severe weakness, as the stock has given back nearly all gains accumulated in late 2025. Volume patterns suggest institutional distribution, with the stock unable to generate any sustained buying interest despite the strategic acquisition announcement. The technical setup heading into March 11 earnings is extremely bearish, with the stock vulnerable to further downside if results disappoint or guidance fails to inspire confidence.

Bull Case

Bear Case

Get a message when the PATH picture changes — the agent team watches the levels and the news for you.Create a free account

More PATH analyses